Autopsy report · NCT04559334
Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients
Cause of deathStaffing, sites or logistics
“There is a new randomized controlled study being coordinated at Cincinatti Children's Hospital (Paul Wales MD, Principal Investigator). Only patients enrolled in this compassionate use study can continue to participate and is closed to new patients.”
Life of this trial
- Registered 3 months before it started.
- Suspended: paused, and may or may not restart.
- 15 participants enrolled.
Vital statistics
- Status
- Suspended
- Phase
- Na
- Sponsor
- Boston Children's Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Central Line Complication; Central Line-associated Bloodstream Infection (CLABSI)
- Interventions
- Tetrasodium EDTA Catheter Lock Solution
- Participants
- 15
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.